Literature DB >> 31650217

18F-FDG PET-MR enterography in predicting histological active disease using the Nancy index in ulcerative colitis: a randomized controlled trial.

Yan Li1, Benedikt Schaarschmidt2, Lale Umutlu2, Michael Forsting2, Aydin Demircioglu2, Anna Katharina Koch3, Ole Martin4, Ken Herrmann5, Hendrik Juette6, Andrea Tannapfel6, Jost Langhorst3,7.   

Abstract

PURPOSE: To evaluate the diagnostic performance of PET-MR enterography in detecting histological active inflammation in patients with ulcerative colitis and the impact of bowel purgation on diagnostic accuracies of PET-MR parameters.
METHODS: Fifty patients were enrolled in this randomized controlled trial (clinicaltrials.gov [NCT03781284]). Forty patients were randomized in two study arms, in which bowel purgation was performed either before or after PET-MR enterography. All patients underwent ileocolonoscopy with mucosal biopsies after PET-MR within 24 h. Diagnostic performance of MR morphological parameters (MRmorph), diffusion-weighted imaging (DWI), and PET in detecting histological inflammation determined by the Nancy index was compared with each other and between study arms. Correlation between PET and histological inflammatory severity was calculated.
RESULTS: In study arm without previous bowel purgation, SUVmax ratio of bowel segment (relative to SUVmax of the liver) facilitated the highest specificity and diagnostic accuracy compared with MRmorph and DWI. Bowel cleansing led to markedly increased metabolic activity of bowel segments, resulting in significantly reduced specificity of PET compared with study arm without purgation (0.808 vs. 0.966, p = 0.007, respectively). Inter-observer concordance for assessing MRmorph was clearly increased after bowel cleansing (Cohen's κ, 0.847 vs. 0.665; p = 0.013, respectively), though diagnostic performance of MRmorph was not significantly improved. Our findings suggested that the change of metabolic status was mainly associated with the grade of neutrophil infiltrate and less dependent on chronic infiltrate.
CONCLUSION: PET-MR enterography was an excellent non-invasive diagnostic method in the assessment of histological active inflammation in ulcerative colitis without the need of previous bowel purgation. TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT03781284.

Entities:  

Keywords:  Inflammatory bowel diseases; PET; PET/MR; Ulcerative colitis

Mesh:

Substances:

Year:  2019        PMID: 31650217     DOI: 10.1007/s00259-019-04535-w

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  28 in total

1.  Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease.

Authors:  Abderrahim Oussalah; Valérie Laurent; Olivier Bruot; Aude Bressenot; Marc-André Bigard; Denis Régent; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

2.  Development and validation of the Nancy histological index for UC.

Authors:  Aude Marchal-Bressenot; Julia Salleron; Camille Boulagnon-Rombi; Claire Bastien; Virginie Cahn; Guillaume Cadiot; Marie-Danièle Diebold; Silvio Danese; Walter Reinisch; Stefan Schreiber; Simon Travis; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2015-10-13       Impact factor: 23.059

3.  Correlation between the endoscopic and histologic score in assessing the activity of ulcerative colitis.

Authors:  Bart Lemmens; Ingrid Arijs; Gert Van Assche; Xavier Sagaert; Karel Geboes; Marc Ferrante; Paul Rutgeerts; Séverine Vermeire; Gert De Hertogh
Journal:  Inflamm Bowel Dis       Date:  2013-05       Impact factor: 5.325

Review 4.  Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications.

Authors:  Daniel Muthas; Anna Reznichenko; Clare A Balendran; Gerhard Böttcher; Ib Groth Clausen; Carina Kärrman Mårdh; Tomas Ottosson; Mohib Uddin; Thomas T MacDonald; Silvio Danese; Mark Berner Hansen
Journal:  Scand J Gastroenterol       Date:  2016-09-27       Impact factor: 2.423

5.  Prognostic value of serologic and histologic markers on clinical relapse in ulcerative colitis patients with mucosal healing.

Authors:  Talat Bessissow; Bart Lemmens; Marc Ferrante; Raf Bisschops; Kristel Van Steen; Karel Geboes; Gert Van Assche; Séverine Vermeire; Paul Rutgeerts; Gert De Hertogh
Journal:  Am J Gastroenterol       Date:  2012-11-13       Impact factor: 10.864

6.  Bowel-cleansing methods affecting PET-CT image interpretation.

Authors:  Dom-Gene Tu; Cheng-Ren Chen; Yu-Wen Wang; Chi-Wen Tu; Yung Cheng Huang
Journal:  Nucl Med Commun       Date:  2011-07       Impact factor: 1.690

7.  PET/MRI for evaluating subclinical inflammation of ulcerative colitis.

Authors:  I-Lun Shih; Shu-Chen Wei; Rouh-Fang Yen; Chin-Chen Chang; Chi-Lun Ko; Been-Ren Lin; Chia-Tung Shun; Kao-Lang Liu; Jau-Min Wong; Yeun-Chung Chang
Journal:  J Magn Reson Imaging       Date:  2017-06-22       Impact factor: 4.813

Review 8.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

9.  Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up.

Authors:  Robert V Bryant; Daniel C Burger; Joseph Delo; Alissa J Walsh; Sally Thomas; Axel von Herbay; Otto C Buchel; Lydia White; Oliver Brain; Satish Keshav; Bryan F Warren; Simon P L Travis
Journal:  Gut       Date:  2015-05-18       Impact factor: 23.059

10.  A practical guide to assess the Nancy histological index for UC.

Authors:  Aude Marchal-Bressenot; Alexis Scherl; Julia Salleron; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2016-08-26       Impact factor: 23.059

View more
  1 in total

1.  Comparison of 18F-FDG PET-MR and fecal biomarkers in the assessment of disease activity in patients with ulcerative colitis.

Authors:  Yan Li; Michael Khamou; Benedikt Michael Schaarschmidt; Lale Umutlu; Michael Forsting; Aydin Demircioglu; Johannes Haubold; Anna Katharina Koch; Nils-Martin Bruckmann; Lino Morris Sawicki; Ken Herrmann; James Hunter Boone; Jost Langhorst
Journal:  Br J Radiol       Date:  2020-06-24       Impact factor: 3.039

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.